Pennsylvania HB 1238: An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.

Status: PN 1302 Referred to JUDICIARY (as of 2021-04-20)

State: Pennsylvania · Session: 2021-2022 · Bill: HB 1238

Sponsors: Quinn, Conklin, Delloso, Madden, Zimmerman

View Pennsylvania HB 1238 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.